Lead optimization in the nondrug-like space

Drug-like space might be more densely populated with orally available compounds than the remaining chemical space, but lead optimization can still occur outside this space. Oral drug space is more dynamic than the relatively static drug-like space. As new targets emerge and optimization tools advanc...

Full description

Saved in:
Bibliographic Details
Published inDrug discovery today Vol. 16; no. 3; pp. 158 - 163
Main Author Zhao, Hongyu
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.02.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Drug-like space might be more densely populated with orally available compounds than the remaining chemical space, but lead optimization can still occur outside this space. Oral drug space is more dynamic than the relatively static drug-like space. As new targets emerge and optimization tools advance the oral drug space might expand. Lead optimization protocols are becoming more complex with greater optimization needs to be satisfied, which consequently could change the role of drug-likeness in the process. Whereas drug-like space should usually be explored preferentially, it can be easier to find oral drugs for certain targets in the nondrug-like space.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1359-6446
1878-5832
DOI:10.1016/j.drudis.2010.12.002